ASTH Astrana Health, Inc.
Services-Management Consulting Services · Nasdaq · SEC CIK 1083446 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY35.1%
TTM net income YoY457.1%
TTM EPS YoY468.4%
Revenue 3-yr CAGR43.4%
Net income 3-yr CAGR6.0%
Margins
Gross margin11.0%
Operating margin3.1%
Net margin1.4%
FCF margin2.5%
EBITDA margin4.7%
Returns
ROE6.5%
ROA2.3%
ROIC (approx.)5.9%
Asset turnover1.71x
Leverage & solvency
Liabilities / assets73.1%
Debt / equity1.08x
Current ratio1.25x
Interest coverage1.87x
Cash quality & payout
Operating cash flow / net income2.15x
Accruals ratio-2.7%
Payout ratio5.1%
Capex / revenue0.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2025Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.02B | $972.52M | $965.10M | $950.53M | $956.05M | $654.81M | $620.39M | $665.21M |
| Cost of revenue | $900.07M | $868.50M | $859.36M | $855.48M | $858.86M | $576.84M | $549.06M | $614.73M |
| Gross profit | $123.55M | $104.02M | $105.74M | $95.04M | $97.19M | $77.97M | $71.33M | $50.48M |
| SG&A expense | $68.05M | $54.15M | $61.74M | $60.25M | $62.39M | $50.73M | $43.90M | $41.63M |
| Operating income | $39.88M | $34.32M | $28.53M | $18.39M | $19.21M | $20.34M | $20.58M | $720,000 |
| Interest expense | $15.02M | $16.00M | $16.10M | $17.52M | $17.72M | $7.38M | $7.31M | $8.07M |
| Pretax income | $32.22M | $27.21M | $19.71M | $7.51M | $5.67M | $16.82M | $9.60M | -$1.90M |
| Income tax | $11.95M | $8.76M | $6.58M | $944,000 | $4.59M | $6.61M | $3.38M | $5.88M |
| Net income | $12.95M | $19.74M | $14.44M | $6.00M | $373,000 | $9.42M | $6.69M | -$6.95M |
| EBITDA | $55.50M | $49.87M | $44.01M | $34.80M | $34.81M | $27.24M | $27.43M | $8.85M |
| EPS (basic) | 0.26 | 0.40 | 0.30 | — | 0.01 | 0.19 | 0.14 | — |
| EPS (diluted) | 0.26 | 0.40 | 0.29 | — | 0.01 | 0.19 | 0.14 | — |
| Weighted avg. shares (diluted) | 49.92M | 49.78M | 49.05M | — | 49.47M | 49.47M | 48.85M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $396.23M | $400.79M | $478.38M | $429.47M | $462.23M | $339.70M | $258.52M | $289.10M |
| Short-term investments | — | — | — | — | $1.22M | $2.42M | $2.40M | $2.38M |
| Receivables | $530.89M | $465.08M | $467.39M | $374.46M | $381.21M | $348.73M | — | $275.99M |
| Current assets | $979.97M | $919.16M | $1.00B | $863.31M | $883.63M | $729.15M | $613.27M | $638.50M |
| PP&E, net | $66.10M | $62.57M | $59.55M | $57.33M | $56.16M | $17.80M | $16.85M | $14.27M |
| Goodwill | $889.39M | $887.00M | $874.80M | $865.30M | $863.27M | $416.92M | $416.39M | $419.25M |
| Intangibles | $229.53M | $243.31M | $257.12M | $270.97M | $285.06M | $105.74M | $111.92M | $118.18M |
| Total assets | $2.34B | $2.28B | $2.36B | $2.22B | $2.24B | $1.44B | $1.33B | $1.35B |
| Current liabilities | $786.07M | $747.64M | $745.37M | $615.27M | $629.93M | $459.75M | $361.27M | $365.61M |
| Short-term debt | $59.83M | $53.85M | $47.87M | $47.87M | $47.87M | $12.50M | $12.50M | $9.38M |
| Long-term debt | $865.55M | $882.65M | $979.76M | $990.90M | $1.00B | $401.06M | $403.89M | $425.30M |
| Total debt | $925.38M | $936.50M | $1.03B | $1.04B | $1.05B | $413.56M | $416.39M | $434.67M |
| Total liabilities | $1.71B | $1.68B | $1.78B | $1.66B | $1.68B | $904.40M | $813.55M | $840.73M |
| Shareholders' equity | $856.62M | $830.22M | $800.27M | $779.29M | $775.54M | $765.46M | $745.37M | $712.72M |
| Net debt | $529.15M | $535.71M | $549.25M | $609.29M | $587.66M | $73.85M | $157.88M | $145.57M |
| Shares outstanding | — | — | — | 48.89M | — | — | — | 47.93M |
| Cash flow statement | ||||||||
| Operating cash flow | $16.27M | $32.75M | $68.06M | -$2.89M | $9.96M | $90.90M | $16.63M | -$10.95M |
| Capital expenditure | $3.83M | $3.88M | $4.00M | $3.06M | $2.55M | $1.42M | $3.07M | $2.53M |
| Free cash flow | $12.44M | $28.87M | $64.06M | -$5.95M | $7.40M | $89.48M | $13.56M | -$13.48M |
| Investing cash flow | -$5.80M | -$6.23M | -$2.84M | -$1.06M | -$534.47M | -$1.08M | -$2.39M | -$33.32M |
| Financing cash flow | -$15.03M | -$104.07M | -$15.96M | -$26.34M | $648.49M | -$8.64M | -$44.17M | -$15.27M |
| Depreciation & amortization | $15.62M | $15.55M | $15.48M | $16.40M | $15.60M | $6.90M | $6.85M | $8.13M |
| Stock-based compensation | $15.60M | $11.80M | $9.89M | $11.38M | $7.70M | $11.70M | $7.81M | $15.23M |
| Dividends paid | $928,000 | $95,000 | $104,000 | $1.56M | $96,000 | $778,000 | $5.46M | $1.92M |
| Share buybacks | $1.10M | $0 | $2.80M | $15.00M | $0 | $0 | $10.60M | $900,000 |
Free plan shows the latest 8 periods; Pro shows all 68 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.